
|Videos|May 12, 2017
Treatment of Malignant Melanoma
Treatment of Malignant Melanoma
Advertisement
- A 46-year-old Caucasian female presented one year ago with deep ulcerated primary tumor and multiple involved lymph nodes.
- She was diagnosed with stage IIIC melanoma.
- Patient underwent wide local incision and compete lymph node dissection and appeared to be clear of disease.
- Patient decided not to pursue adjuvant therapy after surgery.
- Six months after surgery, she developed abdominal pain.
- Imaging showed multiple masses in the liver, > 1 cm, scattered pulmonary nodules and some enlarged lymph nodes.
- Tumor biopsy confirmed melanoma and mutational analysis showed BRAF V600E mutation.
- The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































